Thus, the development of EHMT2-specific inhibitors and the therapeutic application of L. rhamnosus Fb7-311 may represent promising strategies for effective treatment and clinical guidance of RCC treatment. This evidence concerns the gene EHMT2 and renal cell carcinoma.